Inflammatory Bowel Disease Treatment Global Market Report 2024

Description

“Inflammatory Bowel Disease Treatment Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on inflammatory bowel disease treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for inflammatory bowel disease treatment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The inflammatory bowel disease treatment market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

1) By Drug Class: Aminosalicylates; Corticosteroids; TNF inhibitors; IL inhibitors; Anti-integrin; JAK inhibitors; Other Drug Classes
2) By Type: Crohn's Disease; Ulcerative Colitis
3) By Route of Administration: Oral; Injectable
4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy
Companies Mentioned: AbbVie Inc.; Biogen Inc.; Johnson & Johnson; Amgen Inc.; Union Chimique Belge S. A.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Treatment for inflammatory bowel disease involves the use of anti-inflammatory medications commonly employed for mild to moderate cases of ulcerative colitis. Aminosalicylates, including mesalamine (Delzicol, Rowasa, among others), balsalazide (Colazal), and olsalazine, serve as anti-inflammatories, with Dipentum being one of them.

The primary drug categories in the treatment of inflammatory bowel disease encompass aminosalicylates, corticosteroids, TNF inhibitors, IL inhibitors, anti-integrin, JAK inhibitors, and other options. Aminosalicylates, a specific class of drugs, are utilized to manage and prevent flare-ups in ulcerative colitis and Crohn's disease. The mechanism of action of aminosalicylates involves inhibiting the production of cyclo-oxygenase, prostaglandin, thromboxane synthetase, platelet-activating factor synthetase, and interleukin-1 by macrophages. Both orally and via injection, treatments for inflammatory bowel disease are administered for Crohn's disease and ulcerative colitis. These medications are available through hospital pharmacies, retail pharmacies, and online pharmacies.

The inflammatory bowel disease treatment market research report is one of a series of new reports from The Business Research Company that provides inflammatory bowel disease treatment market statistics, including inflammatory bowel disease treatment industry global market size, regional shares, competitors with an inflammatory bowel disease treatment market share, detailed inflammatory bowel disease treatment market segments, market trends and opportunities, and any further data you may need to thrive in the inflammatory bowel disease treatment industry. This inflammatory bowel disease treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The inflammatory bowel disease treatment market size has grown strongly in recent years. It will grow from $23. 49 billion in 2023 to $25. 56 billion in 2024 at a compound annual growth rate (CAGR) of 8. 8%. The rise during the historical period can be ascribed to a heightened prevalence of inflammatory bowel disease, a growing need for biologics and immunomodulators, advancements in treatment choices, an expanding geriatric population, and an increased awareness regarding the disease.

The inflammatory bowel disease treatment market size is expected to see strong growth in the next few years. It will grow to $36. 63 billion in 2028 at a compound annual growth rate (CAGR) of 9. 4%. The expansion projected for the forecast period can be linked to a surge in investment in research and development activities, a rising demand for biosimilars, an increasing incidence of inflammatory bowel disease in emerging markets, a growing preference for personalized medicine, and the integration of precision medicine in IBD treatment. Key trends expected in the forecast period involve a rise in product launches and approvals, the implementation of personalized dosing and treatment plans in IBD management, the utilization of telemedicine for remote monitoring of IBD patients, exploration of microbiome-based therapies for IBD, and the adoption of value-based care models in IBD treatment.

The significant increase in the prevalence of Crohn's disease and ulcerative colitis is a key driver for the growth of the market for inflammatory bowel disease treatment. Crohn's disease and ulcerative colitis, categorized as inflammatory bowel diseases (IBD), involve inflammation and ulcers in the digestive tracts. The growing incidence of these diseases is expected to elevate the demand for treatments that aim to reduce bowel inflammation and prevent medical complications. A March 2022 research publication from the United States National Library of Medicine indicates that approximately 1. 6 million Americans presently suffer from inflammatory bowel disease, with around 70,000 new cases diagnosed annually in the USA. Consequently, the increasing prevalence of Crohn's disease and ulcerative colitis is anticipated to propel the growth of the inflammatory bowel disease treatment market.

The rise in the geriatric population is forecasted to drive the growth of the inflammatory bowel disease treatment market in the future. The geriatric population, comprising individuals aged 65 and older, exhibits a higher susceptibility to inflammatory bowel diseases, resulting in an increased demand for treatments and therapies. This demographic shift is expected to contribute to the expansion of the inflammatory bowel disease treatment market. A report from the World Health Organization (WHO) in October 2022 highlights that by the year 2030, one in six people globally is expected to be 60 or older, and by 2050, there will be an estimated 2. 1 billion people worldwide aged 60 or older. Thus, the growth of the geriatric population is a significant factor propelling the inflammatory bowel disease treatment market.

Technological advancement is a prominent trend gaining traction in the inflammatory bowel disease treatment market. Key market players are actively adopting technologies like artificial intelligence (AI) in drug discovery processes and introducing advanced treatments for inflammatory bowel diseases. Collaboration between major players and technology firms is a prevalent strategy to leverage their respective strengths and technologies for developing new treatments and enhancing their market position. For example, in May 2021, CytoReason, an Israeli technology start-up specializing in a computational model of the human body, partnered with Ferring Pharmaceuticals, a Switzerland-based multinational pharmaceutical company, to utilize artificial intelligence technology in the drug discovery process for new inflammatory bowel disease treatments. The collaboration combines Ferring's medical expertise with CytoReason's AI technology to create cell-centered disease models, providing critical insights into cellular-level functioning and disease treatment.

Major companies in the inflammatory bowel disease treatment market are focusing on the development of innovative products targeting larger customer bases and increasing revenue. Treatments for moderate to severe active ulcerative colitis, involving medications and sometimes surgical interventions, are a key area of innovation. In October 2023, Eli Lilly and Company, a US-based pharmaceutical company, received U. S. Food and Drug Administration (FDA) approval for Omvoh (mirikizumab-mrkz), the first interleukin-23p19 (IL-23p19) antagonist designed to treat adults with moderately to severely active ulcerative colitis (UC). Omvoh targets the IL-23 pathway, effectively blocking inflammation associated with UC. The treatment regimen involves initial infusions followed by subcutaneous self-injections during the maintenance phase.

In March 2022, Pfizer, Inc., a U. S. -based pharmaceutical and biotechnology company, acquired Arena Pharmaceuticals, Inc., for $6. 7 billion. Through this acquisition, Pfizer aims to enhance its research capabilities in the Inflammation and Immunology therapeutic area, develop therapies for immuno-inflammatory diseases, and continue the clinical development of existing drug candidates. Arena Pharmaceuticals, Inc., is a U. S. -based biopharmaceutical company specializing in the development of novel treatments for various immuno-inflammatory conditions.

Major companies operating in the in the inflammatory bowel disease treatment market report are AbbVie Inc., Biogen Inc., Johnson & Johnson, Amgen Inc., Union Chimique Belge S. A., Advanced Gastroenterology and Surgery Associates P. A., Atlanta Gastroenterology Associates LLC, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Cedars-Sinai Medical Center, Celgene Corporation, Cleveland Clinic Foundation, Digestive Disease Associates of Rockland P. C., Eli Lilly and Company, Gastrointestinal Specialists Inc., Gilead Sciences Inc., GlaxoSmithKline plc, Illinois Gastroenterology Group LLC, The Johns Hopkins Hospital Inc., Massachusetts General Hospital, Mayo Clinic, Merck & Co. Inc., Mount Sinai Health System Inc., Novartis International AG, Pfizer Inc., F. Hoffmann-La Roche Ltd, Takeda Pharmaceutical Company Limited, Texas Digestive Disease Consultants P. A., The Oregon Clinic - Gastroenterology West P. C., Ebony 60 Inc., Salix Pharmaceuticals Inc., Shire plc, Vifor Pharma AG, Zydus Pharmaceuticals (USA) Inc.

North America was the largest region in the inflammatory bowel disease treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the inflammatory bowel disease treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the inflammatory bowel disease treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.

The inflammatory bowel disease treatment market includes revenues earned by entities by reducing the inflammation that triggers the signs and symptoms. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified)).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Product Code: r10407

1. Executive Summary

2. Inflammatory Bowel Disease Treatment Market Characteristics

3. Inflammatory Bowel Disease Treatment Market Trends And Strategies

4. Inflammatory Bowel Disease Treatment Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Inflammatory Bowel Disease Treatment Market Size and Growth

5.1. Global Inflammatory Bowel Disease Treatment Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Inflammatory Bowel Disease Treatment Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Inflammatory Bowel Disease Treatment Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Inflammatory Bowel Disease Treatment Market Segmentation

6.1. Global Inflammatory Bowel Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Crohn's Disease
Ulcerative Colitis
6.2. Global Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Aminosalicylates
Corticosteroids
TNF inhibitors
IL inhibitors
Anti-integrin
JAK inhibitors
Other Drug Classes
6.3. Global Inflammatory Bowel Disease Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Oral
Injectable
6. 4. Global Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

7. Inflammatory Bowel Disease Treatment Market Regional And Country Analysis

7.1. Global Inflammatory Bowel Disease Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Inflammatory Bowel Disease Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Inflammatory Bowel Disease Treatment Market

8.1. Asia-Pacific Inflammatory Bowel Disease Treatment Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Inflammatory Bowel Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8. 4. Asia-Pacific Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Inflammatory Bowel Disease Treatment Market

9.1. China Inflammatory Bowel Disease Treatment Market Overview
9.2. China Inflammatory Bowel Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9. 4. China Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Inflammatory Bowel Disease Treatment Market

10.1. India Inflammatory Bowel Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Inflammatory Bowel Disease Treatment Market

11.1. Japan Inflammatory Bowel Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.2. Japan Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Inflammatory Bowel Disease Treatment Market

12.1. Australia Inflammatory Bowel Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Inflammatory Bowel Disease Treatment Market

13.1. Indonesia Inflammatory Bowel Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Inflammatory Bowel Disease Treatment Market

14.1. South Korea Inflammatory Bowel Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.2. South Korea Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Inflammatory Bowel Disease Treatment Market

15.1. Western Europe Inflammatory Bowel Disease Treatment Market Overview
15.2. Western Europe Inflammatory Bowel Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15. 4. Western Europe Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Inflammatory Bowel Disease Treatment Market

16.1. UK Inflammatory Bowel Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Inflammatory Bowel Disease Treatment Market

17.1. Germany Inflammatory Bowel Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Inflammatory Bowel Disease Treatment Market

18. 5. France Inflammatory Bowel Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18. 6. France Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18. 7. France Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Inflammatory Bowel Disease Treatment Market

19. 9. Italy Inflammatory Bowel Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.10. Italy Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.11. Italy Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Inflammatory Bowel Disease Treatment Market

20.13. Spain Inflammatory Bowel Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.14. Spain Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.15. Spain Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Inflammatory Bowel Disease Treatment Market

21.1. Eastern Europe Inflammatory Bowel Disease Treatment Market Overview
21.2. Eastern Europe Inflammatory Bowel Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21. 4. Eastern Europe Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Inflammatory Bowel Disease Treatment Market

22.1. Russia Inflammatory Bowel Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Inflammatory Bowel Disease Treatment Market

23.1. North America Inflammatory Bowel Disease Treatment Market Overview
23.2. North America Inflammatory Bowel Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23. 4. North America Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Inflammatory Bowel Disease Treatment Market

24.1. USA Inflammatory Bowel Disease Treatment Market Overview
24.2. USA Inflammatory Bowel Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24. 4. USA Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Inflammatory Bowel Disease Treatment Market

25.1. Canada Inflammatory Bowel Disease Treatment Market Overview
25.2. Canada Inflammatory Bowel Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25. 4. Canada Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Inflammatory Bowel Disease Treatment Market

26.1. South America Inflammatory Bowel Disease Treatment Market Overview
26.2. South America Inflammatory Bowel Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26. 4. South America Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Inflammatory Bowel Disease Treatment Market

27.1. Brazil Inflammatory Bowel Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Inflammatory Bowel Disease Treatment Market

28.1. Middle East Inflammatory Bowel Disease Treatment Market Overview
28.2. Middle East Inflammatory Bowel Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28. 4. Middle East Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Inflammatory Bowel Disease Treatment Market

29.1. Africa Inflammatory Bowel Disease Treatment Market Overview
29.2. Africa Inflammatory Bowel Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29. 4. Africa Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Inflammatory Bowel Disease Treatment Market Competitive Landscape And Company Profiles

30.1. Inflammatory Bowel Disease Treatment Market Competitive Landscape
30.2. Inflammatory Bowel Disease Treatment Market Company Profiles
- 30.2.1. AbbVie Inc.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1. 4. Financial Performance
- 30.2.2. Biogen Inc.
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2. 4. Financial Performance
- 30.2.3. Johnson & Johnson
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3. 4. Financial Performance
- 30.2. 4. Amgen Inc.
  - 30.2. 4.1. Overview
  - 30.2. 4.2. Products and Services
  - 30.2. 4.3. Strategy
  - 30.2. 4. 4. Financial Performance
- 30.2. 5. Union Chimique Belge S. A.
  - 30.2. 5.1. Overview
  - 30.2. 5.2. Products and Services
  - 30.2. 5.3. Strategy
  - 30.2. 5. 4. Financial Performance

31. Global Inflammatory Bowel Disease Treatment Market Competitive Benchmarking

32. Global Inflammatory Bowel Disease Treatment Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Inflammatory Bowel Disease Treatment Market

34. Inflammatory Bowel Disease Treatment Market Future Outlook and Potential Analysis

34.1 Inflammatory Bowel Disease Treatment Market In 2028 - Countries Offering Most New Opportunities
34.2 Inflammatory Bowel Disease Treatment Market In 2028 - Segments Offering Most New Opportunities
34. 3 Inflammatory Bowel Disease Treatment Market In 2028 - Growth Strategies
- 34.3.1 Market Trend Based Strategies
- 34.3.2 Competitor Strategies

35. Appendix

35.1. Abbreviations
35.2. Currencies
35.3. Historic And Forecast Inflation Rates
35. 4. Research Inquiries
35. 5. The Business Research Company
35. 6. Copyright And Disclaimer